檢索結果 - Corey Cutler

Refine Results
  1. 1
    A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome

    A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved out... 由 Corey Cutler

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    How we treat higher-risk myelodysplastic syndromes

    How we treat higher-risk myelodysplastic syndromes 由 Mikkael A. Sekeres, Corey Cutler

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Peripheral Blood Stem Cells for Allogeneic Transplantation: A Review

    Peripheral Blood Stem Cells for Allogeneic Transplantation: A Review 由 Corey Cutler, Joseph H. Antin

    出版 2001
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Mechanistic approaches for the prevention and treatment of chronic GVHD

    Mechanistic approaches for the prevention and treatment of chronic GVHD 由 Corey Cutler, John Koreth, Jerome Ritz

    出版 2016
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    B Cells in Chronic Graft-versus-Host Disease

    B Cells in Chronic Graft-versus-Host Disease 由 Stefanie Sarantopoulos, Bruce R. Blazar, Corey Cutler, Jerome Ritz

    出版 2014
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    How we treat oral chronic graft-versus-host disease

    How we treat oral chronic graft-versus-host disease 由 Nathaniel S. Treister, Christine Duncan, Corey Cutler, Leslie E. Lehmann

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Efficacy of Rituximab in the Setting of Steroid-Refractory Chronic Graft-versus-Host Disease: A Systematic Review and Meta-Analysis

    Efficacy of Rituximab in the Setting of Steroid-Refractory Chronic Graft-versus-Host Disease: A Systematic Review and Meta-Analysis 由 Mohamed A. Kharfan‐Dabaja, Asmita Mhaskar, Benjamin Djulbegović, Corey Cutler, Mohamad Mohty, Ambuj Kumar

    出版 2009
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  8. 8
    Decision Analysis of Peripheral Blood versus Bone Marrow Hematopoietic Stem Cells for Allogeneic Hematopoietic Cell Transplantation

    Decision Analysis of Peripheral Blood versus Bone Marrow Hematopoietic Stem Cells for Allogeneic Hematopoietic Cell Transplantation 由 Joseph Pidala, Claudio Anasetti, Mohamed A. Kharfan‐Dabaja, Corey Cutler, Andy Sheldon, Benjamin Djulbegović

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation

    Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation 由 Corey Cutler, Shuli Li, Vincent T. Ho, John Koreth, Edwin P. Alyea, Robert J. Soiffer, Joseph H. Antin

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy

    Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy 由 Akiko Saito, David Zahrieh, Corey Cutler, Vincent T. Ho, Joseph H. Antin, Robert J. Soiffer, Edwin P. Alyea, S J Lee

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    High Levels of B-Cell Activating Factor in Patients with Active Chronic Graft-Versus-Host Disease

    High Levels of B-Cell Activating Factor in Patients with Active Chronic Graft-Versus-Host Disease 由 Stefanie Sarantopoulos, Kristen E. Stevenson, Haesook T. Kim, Nazmim S. Bhuiya, Corey Cutler, Robert J. Soiffer, Joseph H. Antin, Jerome Ritz

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation

    Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation 由 Philippe Armand, Haesook T. Kim, Corey Cutler, Vincent T. Ho, John Koreth, Edwin P. Alyea, Robert J. Soiffer, Joseph H. Antin

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials

    Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials 由 Zachariah DeFilipp, Haesook T. Kim, Zhongming Yang, John T. Noonan, Bruce R. Blazar, Stephanie J. Lee, Steven Z. Pavletic, Corey Cutler

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Outcome and Prognostic Factors for Patients Who Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

    Outcome and Prognostic Factors for Patients Who Relapse after Allogeneic Hematopoietic Stem Cell Transplantation 由 Gita Thanarajasingam, Haesook T. Kim, Corey Cutler, Vincent T. Ho, John Koreth, Edwin P. Alyea, Joseph H. Antin, Robert J. Soiffer, Philippe Armand

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and Mini-Methotrexate (Tac/Sir/MTX) as Acute Graft-versus-Host Disease Prophylaxis after Reduced-Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation

    Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and Mini-Methotrexate (Tac/Sir/MTX) as Acute Graft-versus-Host Disease Prophylaxis after Reduced-Inte... 由 Vincent T. Ho, Julie Aldridge, Haesook T. Kim, Corey Cutler, John Koreth, Philippe Armand, Joseph H. Antin, Robert J. Soiffer, Edwin P. Alyea

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Costs of Allogeneic Hematopoietic Cell Transplantation with High-Dose Regimens

    Costs of Allogeneic Hematopoietic Cell Transplantation with High-Dose Regimens 由 Akiko Saito, Corey Cutler, David Zahrieh, Robert J. Soiffer, Vincent T. Ho, Edwin P. Alyea, John Koreth, Joseph H. Antin, Stephanie J. Lee

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post–allogeneic HCT

    Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post–allogeneic HCT 由 Mohammad Abu Zaid, Juan Wu, Cindy Wu, Brent R. Logan, Jeffrey Yu, Corey Cutler, Joseph H. Antin, Sophie Paczesny, Sung Won Choi

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation

    Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation 由 Vincent T. Ho, Corey Cutler, Shelly Carter, Paul J. Martin, Roberta Adams, Mary M. Horowitz, James L.M. Ferrara, Robert J. Soiffer, Sergio Giralt

    出版 2005
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  19. 19
    Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Patients Over 60 Years: Hematologic Malignancy Outcomes Are Not Impaired in Advanced Age

    Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Patients Over 60 Years: Hematologic Malignancy Outcomes Are Not Impaired in Advanced Age 由 John Koreth, Julie Aldridge, Haesook T. Kim, Edwin P. Alyea, Corey Cutler, Philippe Armand, Jerome Ritz, Joseph H. Antin, Robert J. Soiffer, Vincent T. Ho

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS)

    Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS) 由 Wael Saber, Corey Cutler, Ryotaro Nakamura, Mei-Jie Zhang, Ehab Atallah, J. Douglas Rizzo, Richard T. Maziarz, Jorge E. Cortés, Matt Kalaycio, Mary M. Horowitz

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: